10.1038/onc.2017.38 Summary Keywords alcohol-associated liver disease (ALD), glucagon-like peptide 1 receptor agonists (GLP-1 RAs), metabolic dysfunction and alcohol-associated liver disease (MetALD), metabolic dysfunction-associated steatotic liver disease (MASLD), steatotic liver disease (SLD) Citation Mahalingam S, Kharbanda KK, Casey CA and Rasineni K (2026) Beyond diabetes and obesity: GLP-1 receptor agonists as multifunctional therapeutics across the steatotic liver disease spectrum
You sometimes need to show that youve participated in a comprehensive weight management program for at least 6 months
the results showed that treatment effect estimates were not influenced by site and that the results were directionally consistent across sex (Extended Data Table 3)
[5] Sleep Architecture Modulation : Animal and limited human studies indicate that DSIP may increase the duration of slow-wave sleep without significantly affecting rapid eye movement (REM) sleep, which could support improved restorative sleep and cognitive function
Similarly, oral glutathione supplements have historically been considered poorly bioavailable, though newer formulations (liposomal, sublingual, S-acetyl) aim to improve this [1][12]
For patients with recurrent UTIs, a multi-faceted approach that combines lifestyle changes, medical interventions, and personalized care can be effective in reducing the frequency of infections
